Covalon Technologies (OTCMKTS:CVALF) Stock Price Up 4.6% – Still a Buy?

Covalon Technologies Ltd. (OTCMKTS:CVALF) shares shot up 4.6% during trading on Wednesday . The stock traded as high as $1.56 and last traded at $1.5375. Approximately 4,208 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 9,632 shares. The stock had previously closed at $1.47.

Covalon Technologies Stock Performance

The stock’s 50-day simple moving average is $1.50 and its two-hundred day simple moving average is $1.37. The stock has a market cap of $41.15 million, a price-to-earnings ratio of 37.26 and a beta of 0.63.

Covalon Technologies (OTCMKTS:CVALF) last issued its quarterly earnings results on Thursday, May 21st. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.02. Covalon Technologies had a return on equity of 5.77% and a net margin of 5.05%.The company had revenue of $6.27 million for the quarter, compared to the consensus estimate of $6.70 million.

Covalon Technologies Company Profile

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.

The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.